Has CRISPR Therapeutics (CRSP) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 02/24/23
CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 02/22/23
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewsWire • 02/21/23
CRISPR Therapeutics AG (CRSP) SVB Securities Global Biopharma Conference (Transcript)Seeking Alpha • 02/16/23
Wall Street Expects This Stock to Jump 70% This Year. Here's Why It Could Happen.The Motley Fool • 02/09/23
Strength Seen in CRISPR Therapeutics AG (CRSP): Can Its 7.2% Jump Turn into More Strength?Zacks Investment Research • 02/03/23